188040 — Bio Port Korea Cashflow Statement
0.000.00%
- KR₩28bn
- KR₩22bn
- KR₩71bn
Annual cashflow statement for Bio Port Korea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 3,369 | 4,112 | -1,403 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 2,518 | 5,045 | 2,732 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -5,274 | 1,056 | 1,034 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Taxes Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 2,022 | 12,074 | 4,741 |
| Capital Expenditures | -3,275 | -3,584 | -2,349 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | 2,653 | 2,145 | 4,141 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -622 | -1,439 | 1,792 |
| Financing Cash Flow Items | 151 | — | 1,005 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 2,324 | -6,364 | -3,748 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3,741 | 4,328 | 2,697 |